Form validation的問題，透過圖書和論文來找解法和答案更準確安心。 我們找到下列特價商品、必買資訊和推薦清單

The Emotionally Exhausted Woman: Why You’’re Feeling Depleted and How to Get What You Need

為了解決Form validation的問題，作者Colier, Nancy 這樣論述：

Are you feeling emotionally exhausted? Do you worry about being likable (at all cost)? Are you trying to do it all and be it all--all the time? This radically different self-care guide will help you find the courage needed to express your deepest needs, nurture self-awareness, and be yourself in

a world that expects you to be everything to everyone.If you’re like countless other women today, you probably feel overwhelmed, emotionally exhausted, anxious, stressed, frustrated, or unsatisfied. Or all of the above! In addition to managing your own career and running a household, you may be taki

ng on an abundance of emotional labor--tending to others’ needs at the expense of your own. If you’ve spent your whole life trying to please and manage other peoples’ experience, it’s time to speak your truth out loud, stand in your own shoes, and live an authentic life--rather than just behave. Wri

tten by therapist and spiritual teacher Nancy Colier, The Emotionally Exhausted Woman offers the validation, emotional support, and empowering skills you’ve been craving. You’ll discover insights grounded in self-respect and awareness, to help you be on your own side and uncover your deepest psychol

ogical, spiritual, and emotional needs without feeling guilt, shame, or judgment. You’ll learn why you are feeling depleted, why you take care of others at the expense of taking care of yourself, and how to develop a deeper form of self-care beyond the temporary respite of a spa retreat, bubble bath

, or manicure. Finally, you’ll nurture greater awareness of what you truly need to achieve lasting vitality and fulfillment.As women, we are culturally conditioned to believe that we should be able to do it all and should be all things to all people--all while smiling, looking perfect, and needing n

othing for ourselves. At the end of the day, these pressures can leave us feeling depleted--in body, mind, and spirit. So, how can you start taking care of you in a deeper way? This empowering guide will help you gain a newfound awareness of your own needs, and find the courage to live a life that b

oth nourishes and inspires you.

Form validation進入發燒排行的影片

以疾病不確定感理論發展整合性心動健康網路照顧模式提升心房顫動病人因應策略之成效探討

為了解決Form validation的問題，作者謝慧玲 這樣論述：

正文目錄正文目錄『表』目錄 IV『圖』目錄 V『附錄』目錄 VII中文摘要 VIII英文摘要 X第一章 緒論 1 第一節 研究背景、動機及重要性 1 第二節 研究目的 7第二章 文獻查證 8 第一節 心房顫動疾病簡介 8 第二節 疾病不確定感理論 15 第三節 疾病不確定感相關研究 22 第四節 整合性健康網路照顧模式的發展及運用 31第三章 研究架構與假設 36 第一節 研究架構 36 第二節 研究假設 37 第三節 名詞界定 38第四章 研究方法與過程 43 第一節 研究設計 43 第二節 研究對象及場所 45 第三節 研究工具 46

第四節 研究工具之信效度檢定 52 第五節 研究過程 59 第六節 研究倫量 63 第七節 資料處理與統計分析 64第五章 研究結果 66 第一節 心房顫動病人的基本屬性68 第二節 心房顫動病人的症狀困擾、疾病知識、社會支持、疾病不確定感、因應策略及心理困擾之前後測情形 76 第三節 介入「整合性心動健康網路照顧模式」對於心房顫動病人症狀困擾、疾病知識、社會支持、疾病不確定感、因應策略及心理困擾之成效 85第六章 討論 107 第一節 心房顫動病人的基本屬性現況分析 108 第二節 介入「整合性心動健康網路照顧模式」對於改善心房顫動病人症狀困擾之成效 111

第三節 介入「整合性心動健康網路照顧模式」對於改善心房顫動病人疾病知識之成效 113 第四節 介入「整合性心動健康網路照顧模式」對於改善心房顫動病人社會支持之成效 115 第五節 介入「整合性心動健康網路照顧模式」對於改善心房顫動病人疾病不確定感之成效 117 第六節 介入「整合性心動健康網路照顧模式」對於改善心房顫動病人因應策略之成效 119 第七節 介入「整合性心動健康網路照顧模式」對於改善心房顫動病人心理困擾之成效 121 第八節 研究限制 124第七章 結論與建議 125 第一節 結論 125 第二節 建議 127參考文獻 129附錄 141『表』目錄表1. 資料處理

與分析 65表2. 心房顫動病人之人口基本屬性 70表3. 心房顫動病人的疾病特性 74表4. 心房顫動病人症狀困擾、疾病知識、社會支持、疾病不確定感、因應策略及心理困擾之前測與後測結果 83表5. 以 GEE 方法探討整合性心動健康網路照顧模式於心房顫動病人症狀困擾改變之成效 86表6. 以 GEE 方法探討整合性心動健康網路照顧模式於心房顫動病人疾病知識改變之成效 89表7. 以GEE方法探討整合性心動健康網路照顧模式於心房顫動病人社會支持改變之成效 92表8. 以GEE方法探討整合性心動健康網路照顧模式對於心房顫動病人疾病不確定感之改變成效 95表9. 以GEE方法探討整合性心動健康網路

照顧模式對於心房顫動病人因應策略改變之成效 98表10. 以GEE方法探討整合性心動健康網路照顧模式對於心房顫動病人心理困擾改變之成效 103『圖』目錄圖1. 不確定感理論架構 21圖2. 研究架構圖 36圖3. 研究設計 44圖4. 流程圖 67圖5. 兩組在第三版症狀頻率-嚴重程度評估量表之症狀頻率次量表平均分數於前測、後測第一個月、第三個月與第六個月的變化 87圖6. 兩組在心房顫動知識量表平均分數於前測、後測第一個月、第三個月與第六個月的變化 90圖7. 兩組在醫療社會支持量表平均分數於前測、後測第一個月、第三個月與第六個月的變化 93圖8. 兩組在中文版Mishel疾病不確定感量表平

均分數於前測、後測第一個月、第三個月與第六個月的變化 96圖9. 兩組在簡易因應量表之應對因應策略次量表平均分數於前測、後測第一個月、第三個月與第六個月的變化 99圖10. 兩組在簡易因應量表之迴避因應策略次量表平均分數於前測、後測第一個月、第三個月與第六個月的變化 100圖11. 兩組在醫院焦慮憂鬱量表平均分數於前測、後測第一個月、第三個月與第六個月的變化 104圖12. 兩組在醫院焦慮憂鬱量表之焦慮次量表平均分數於前測、後測第一個月、第三個月與第六個月的變化 105圖13. 兩組在醫院焦慮憂鬱量表之憂鬱次量表平均分數於前測、後測第一個月、第三個月與第六個月的變化 106『附錄』目錄附錄一

心房顫動病人基本屬性量表 附錄一附錄二 第三版症狀頻率-嚴重程度評估量表之症狀頻率次量表 附錄二附錄三 心房顫動知識量表 附錄三附錄四 醫療社會支持量表 附錄四附錄五 中文版Mishel疾病不確定感量表 附錄五附錄六 簡易因應量表 附錄六附錄七 醫院憂鬱焦慮量表 附錄七

Physician’’s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases

為了解決Form validation的問題，作者 這樣論述：

Nenad Blau is a senior consultant in biochemical genetics at the Division of Metabolism, University Children’s Hospital in Zürich (UZH), Switzerland. Previously he was the head of the Laboratory for Tetrahydrobiopterin and Neurotransmitter Diseases at the University Children’s Hospital in Zurich and

for the last 8 years as a senior consultant in biochemical genetics at the University Children’s Hospital in Heidelberg, Germany. His research group discovered several inborn errors of metabolism, including GTP cyclohydrolase deficiency, pterin-carbinolamine dehydratase deficiency, and sepiapterin

reductase deficiency. He established and curates the PAH locus-specific database, database of PKU genotypes and phenotypes, and database of BH4 deficiencies. With colleagues from Vancouver he developed the online knowledgebase of inborn errors of metabolism, IEMbase. He is author of more than 400 re

search publications, including the standard books Physician’s Guide to the Laboratory Diagnosis, Treatment and Follow-up of Inherited Metabolic Disease, and Laboratory Guide to the Methods in Biochemical Genetics. Professor Blau is an honorary member of the Italian Society for Pediatrics. For his re

search in the field of tetrahydrobiopterin and phenylketonuria he received the Horst-Bickel Award in 2001, the Gowland Hopkins Award in 2005, and he received the Asbjørn Følling award in 2011.Carlo Dionisi-Vici obtained his residency in Paediatrics at ＂La Sapienza＂ University, Rome, Italy. He is the

head of the Division of Metabolic Diseases and of the Research Unit for Metabolic Diseases at the Bambino Gesù Children’s Research Hospital, Rome. Dr Dionisi-Vici is the past-president of the Italian Society for the Study of Inborn Errors of Metabolism (SIMMESN), and was a council member of the Soc

iety for the Study of Inborn Errors of Metabolism (SSIEM) from 2010 to 2016. His clinical work and research focus on the field of inborn errors of metabolism, including defects of intermediary metabolism, subcellular organelle disorders and inherited defects of intracellular vesicular trafficking. W

ith his research group, he participated in the discovery of new inborn errors of metabolism, including ethylmalonic encephalopathy, MEDNIK syndrome, and Vici syndrome. He is the author of more than 250 peer-reviewed publications. Within the MetabERN consortium he is responsible for the work-package

guidelines and for the sub-network carbohydrate and fatty acid oxidation disorders. Carlos R. Ferreira is board-certified in Internal Medicine, Medical Genetics, and Clinical Biochemical Genetics, and specializes in genetic disorders of bone development and inborn errors of metabolism. He led a team

of researchers that elucidated the molecular defect underlying Saul-Wilson syndrome, a rare disorder of vesicular trafficking leading to skeletal dysplasia. He contributed to the finding of disturbed tryptophan catabolism as a new etiology of Catel-Manzke syndrome (another rare constitutional disor

der of bone development), and to finding the cause of a rare hematologic disorder, combined alpha-delta platelet storage pool deficiency. He was part of several collaborations that led to the discovery of novel genetic disorders, including a primary CoQ10 biosynthetic defect (COQ5 deficiency), a gen

etic form of renal Fanconi syndrome due to GATM aggregates, a rare neuromuscular defect (Carey-Fineman-Ziter syndrome), a novel neurodegenerative condition (TRAK1 deficiency), and a skeletal dysplasia in the dysosteosclerosis-Pyle disease spectrum. Dr. Ferreira participates as faculty in the annual

North American Metabolic Academy (NAMA) course. He has authored more than 90 indexed publications, one of which recently received the Emmanuel Shapira Award (bestowed to the best paper published in Molecular Genetics and Metabolism).Christine Vianey-Saban is the former Head of the Department for Inb

orn Errors of Metabolism and Newborn Screening at the Centre de Biologie et de Pathologie Est in Lyon. She was trained in Pharmacy and obtained a PhD degree in Biochemistry at the University of Lyon. Her research is focused on the enzymatic and molecular bases of mitochondrial fatty acid oxidation a

nd riboflavin metabolism as well as on the development and the validation of new markers for the diagnosis of inborn errors of metabolism using tandem mass spectrometry. She is co-author of more than 150 peer-reviewed publications in international scientific journals and of 10 book chapters. She was

invited speaker and chaired sessions in many international meetings. Dr Vianey-Saban is a founding member of the French society for inborn errors of metabolism (SFEIM), and lectures for the French University Diploma on Inborn Errors of Metabolism. She is Chair of the Scientific Advisory Board of ER

NDIM (European Research Network for the evaluation and improvement of screening, Diagnosis and treatment of Inherited disorders of Metabolism) and is responsible for the quality assessment program « ERNDIM Diagnostic Proficiency Testing France ». She has been a member of the SSIEM Council, she has o

rganized the SSIEM Annual Symposium in Lyon in 2015 and is Senior Advisor for the SSIEM’s Education and Training Advisory Committee. Clara van Karnebeek is head of the metabolic diseases department in the Radboud University Medical Centre in Nijmegen and principal investigator at the Amsterdam Unive

rsity Medical Centres, The Netherlands and the University of British Columbia in Vancouver Canada. Clara’s work as a pediatrician and biochemical geneticist focuses on early diagnosis and innovative treatment of neurometabolic diseases in a P4-medicine model. Her international team integrates genomi

c and metabolomics technologies to unravel the cause of degenerative brain conditions in children, discovering novel genetic conditions and treatment targets. She implements this knowledge in the management of her patients, via clinical trials with personalized outcomes. Translating new knowledge in

to expanded newborn screening, as well as useful information and action for the patient and family, using digital applications, are the ultimate goals of her multi-disciplinary team’s effort. She is the Director of United for Metabolic Diseases, a Dutch consortium uniting all 6 academic metabolic ex

pertise centers and the patient organizations to optimize research and care. She published over 180 peer-reviewed journal articles, multiple clinical guidelines and chapters in textbooks. She is a dedicated teacher and mentor for clinical and research trainees at different stages. For her contributi

ons to research and clinical care and commitment to translational science she received the Canadian Organization for Rare Diseases Scientist Award

教練型領導組織承諾的關係:以組織創新活力為中介變項

為了解決Form validation的問題，作者賴世耕 這樣論述：

教練型領導是通過鼓勵、指導、授權等方式樹立工作目標，最終實現領導者和員工之間相互促進以及共同發展。透過提高組織創新活力，來提高組織承諾，使員工達到對企業有緊密的關係，並且提高創新活力，以利組織面對環境改變越來越快速的問題。本研究之搜取樣本方法使用便利抽樣方式，而研究對象為台灣企業之員工，須在公司滿3個月以上工作經驗，並具有團隊經驗，以網路問卷發放，共回收452份問卷，刪除無效問卷後共409份，有效問卷之回收率為90.48%。在統計數據顯示，假設一為教練型領導對整體組織承諾具有顯著正向影響(β=.712 , p < .001)，故假設一成立。假設二教練型領導對整體組織創新活力具有顯著正向影響(

β=.749 , p < .001)，故假設二的推論成立。假設三組織創新活力對整體組織承諾具有顯著正向影響(β=.846 , p < .001)，假設三的推論成立。假設四組織創新活力中介教練型領導與組織承諾之間在加入組織創新活力的中介變項後，教練型領導對組織承諾的影響力下降(β= .712 , p < .001、β= .183 , p < .001)，故假設四成立。根據上述的假設成立給予實務上的建議，首先，在現今大數據時代的來臨，若組織內部的領導者具有教練型領導風格，可以帶給員工更高的組織承諾；在面對需要快速創新的產業與組織，教練型領導能夠促進組織創新活力，是組織面對創新更有動能；在組織中的組

織創新活力的程度越高，會更吸引組織內部的成員提高歸屬感與承諾；在了解組織創新活力中介於教練型領導與組織承諾之間，可以更能夠了解，組織內部員工對於領導者與組織需要能夠帶來協助與好的溝通才有辦法讓員工有所歸屬。